Metraipolis › archive › dc_85990810490c

Harnessing human immune system models to validate NADPH oxidase 1 inhibition as treatment for hepatocellular carcinoma — Europe PMC PMID:42523594

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42523594
DOI
10.3389/fphar.2026.1808515
License (as archived)
solo-consultazione
Archived
2026-10-18T07:12:17.122Z
SHA-256 of the archived text
0f8586631ae8057dba1cf3c50634c8111ebe8a45cd4dd5e72abd49a15272d49e
Stable URL of this page
https://metraipolis.com/documento/dc_85990810490c

How to cite

Harnessing human immune system models to validate NADPH oxidase 1 inhibition as treatment for hepatocellular carcinoma — Europe PMC PMID:42523594 — Europe PMC (en), https://europepmc.org/article/MED/42523594 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_85990810490c (Metraipolis archive dc_85990810490c, sha256 0f8586631ae8057dba1cf3c50634c8111ebe8a45cd4dd5e72abd49a15272d49e)
BibTeX
@misc{dc85990810490c,
  title = {Harnessing human immune system models to validate NADPH oxidase 1 inhibition as treatment for hepatocellular carcinoma — Europe PMC PMID:42523594},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42523594},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_85990810490c; sha256 0f8586631ae8057dba1cf3c50634c8111ebe8a45cd4dd5e72abd49a15272d49e},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42523594. Agents can read the archived copy with the MCP tool read_document.